Roche
Roche
Revolutionary Method Triples sgRNA Yields and Purity!
🌟 Discover how the new chemo-enzymatic method triples sgRNA yields and boosts purity, revolutionizing gene editing! 🔬📊 Biotech Innovation
Roche’s $50B US Boost: Jobs and Growth Ahead!
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Lonza Boosts US Manufacturing with $12B Acquisition!
🚀 Lonza has acquired Roche's Vacaville site for $1.2 billion, boosting U.S. manufacturing and investing $591 million for upgrades! 🏭✨
Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss
🌍 Roche's obesity drug CT-388 shows impressive results in clinical trial, offering hope for weight loss worldwide! 💊💪 ObesitySolution
Roche’s Breakthrough Obesity Drug: 188 Weight Loss!
🔍 Roche's CT-388 shows promising results in treating obesity, with a median weight loss of 18.8 in Phase I trial. 📈💊🩺
Boost Productivity & Cut Costs: Power of Digitization and Automation
🔍 Implementing a Digitization and Automation Strategy: Reduce costs and increase productivity with digitalization and automation! Roche's success story. 🚀🔬🤖
Roche’s €90m Gene Therapy Hub Revolutionizes Research
Roche opens €90m gene therapy development centre in Germany 🏢🧬💉💊 to advance gene therapy research worldwide 🌍.
Roche Leads $257M Funding for Cancer Detection Breakthrough
🔹 Roche AG leads $257m financing for Freenome Inc., supporting AI-powered blood test for early cancer detection. 🩺💰💉
Roche Abandons AC Immune Collaboration Returns Drugs
📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅
Breakthrough Antibiotic Kills Superbug and Saves Lives
🔬 Roche presents resistance-breaking antibiotic! 🦠 Zosurabalpin kills carbapenem-resistant Acinetobacter baumannii by preventing lipopolysaccharide movement. 🧪🐭 MedicalAdvancements
